Tagged buprenorphine

Addinex Technologies Awarded $260K Grant by the CDC to Improve Addiction Medication Dispensing
Press Release

Addinex Technologies Awarded $260K Grant by the CDC to Improve Addiction Medication Dispensing

 Addinex will work with Yale School of Medicine, Aware Recovery Care, and the In-Home Addiction Treatment Institute to adapt its award-winning opioid dispensing system Read More
Cordant Health Solutions Opens New Addiction Treatment Pharmacies in Illinois, Ohio and Oklahoma
Press Release

Cordant Health Solutions Opens New Addiction Treatment Pharmacies in Illinois, Ohio and Oklahoma

 With the addition of these new locations, Cordant's managed medication-assisted treatment (MAT) pharmacy program Cordant Pharmacy Solutions™ now serves more than 17,000 patients in 12 states Read More
New Study Demonstrates Cordant's Pharmacy Program Helps Patients With Opioid Use Disorder Overcome Barriers to Treatment
Press Release

New Study Demonstrates Cordant's Pharmacy Program Helps Patients With Opioid Use Disorder Overcome Barriers to Treatment

 A new study reveals that patients in Cordant's managed medication-assisted treatment pharmacy program feel less stigma and stay adherent to their treatment plan Read More
Press Release

Bridge Therapeutics Announces It Will Seek FDA Approval for BT-219, a Treatment for Opioid Dependence in the Coming Months

 Read More
Press Release

Recovery Delivered Announces Daniel Karlin as Senior Advisor

 Read More
Recovery Delivered Launches Online Opioid Use Disorder Treatment in Ohio to Provide Greater Access to Buprenorphine/Naloxone
Press Release

Recovery Delivered Launches Online Opioid Use Disorder Treatment in Ohio to Provide Greater Access to Buprenorphine/Naloxone

 Read More
Bridge Therapeutics Announces the Addition of Edward J. Minskoff to Its Board of Directors
Press Release

Bridge Therapeutics Announces the Addition of Edward J. Minskoff to Its Board of Directors

 Read More
Press Release

Bridge Therapeutics Announces the Addition of Dr. Bob Rappaport to Its Scientific Advisory Board

 Dr. Bob Rappaport joins Bridge Therapeutics' Scientific Advisory Board as its newest member Read More
Press Release

Bridge Therapeutics is Selected as a Finalists for the RESI 2018 Innovation Challenge

 Bridge Therapeutics will present a poster presentation at the RESI Conference November 4, 2018, in New York. Read More